Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms

Psychoneuroendocrinology

Volumn 38, Issue 3, 2013, Pages 387-398

  Ellenbogen, Mark A ^a   Linnen, Anne Marie ^a   Cardoso, Christopher ^a   Joober, Ridha ^b  

^a Civil and Environmental Engineering   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Depression; Emotional pictures; Inhibition; Negative priming; Oxytocin

Indexed keywords

OXYTOCIN; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; EMOTION; FACIAL EXPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; INHIBITION (PSYCHOLOGY); MALE; NEGATIVE AFFECTIVE PRIMING TASK; NEUROSIS; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SADNESS; TASK PERFORMANCE; UNIVERSITY STUDENT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AFFECT; DEPRESSION; DOUBLE-BLIND METHOD; FACIAL EXPRESSION; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; OXYTOCIN; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REPETITION PRIMING; VISUAL PERCEPTION;

EID: 84875246624     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.06.016     Document Type: Article

References (104)

1. Aiken L.S., West S.G. Multiple Regression: Testing and Interpreting Interactions 1991, Sage, Newbury Park, CA.
2. Amico J.A., Tenicela R., Johnston J., Robinson A.G. A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. J. Clin. Endocrinol. Metab. 1983, 57:947-951.
3. Amico J.A., Janosky J.E., Challinor S.M., Cameron J.L. Effect of naloxone administration upon the diurnal concentrations of oxytocin in the cerebrospinal fluid of rhesus and cynomolgus monkeys. Horm. Res. 1992, 38:171-176.
4. Amir N., Cobb M., Morrison A.S. Threat processing in obsessive-compulsive disorder: evidence from a modified negative priming task. Behav. Res. Ther. 2008, 46:728-736.
5. Barraza J.A., Zak P.J. Empathy toward strangers triggers oxytocin release and subsequent generosity. Ann. N.Y. Acad. Sci. 2009, 1167:182-189.
6. Bartz J., Simeon D., Hamilton H., Kim S., Crystal S., Braun A., Vicens V., Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc. Cogn. Affect. Neur. 2011, 6:556-563.
7. Bartz J.A., Zaki J., Bolger N., Hollander E., Ludwig N.N., Kolevzon A., Ochsner K.N. Oxytocin selectively improves empathic accuracy. Psychol. Sci. 2010, 21:1426-1428.
8. Bartz J.A., Zaki J., Ochsner K.N., Bolger N., Kolevzon A., Ludwig N., Lydon J.E. Effects of oxytocin on recollections of maternal care and closeness. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21371-21375.
9. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
10. Baumgartner T., Heinrichs M., Vonlanthen A., Fischbacher U., Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008, 58:639-650.
11. Beauregard M., Paquette V., Levesque J. Dysfunction in the neural circuitry of emotional self-regulation in major depressive disorder. Neuroreport 2006, 17:843-846.
12. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
13. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516.
14. Bosch O.J. Maternal nurturing is dependent on her innate anxiety: the behavioral roles of brain oxytocin and vasopressin. Horm. Behav. 2011, 59:202-212.
15. Buchheim A., Heinrichs M., George C., Pokorny D., Koops E., Henningsen P., O'Connor M.-F., Gnndel H. Oxytocin enhances the experience of attachment security. Psychoneuroendocrinology 2009, 34:1417-1422.
16. Campbell A. Attachment, aggression and affiliation: the role of oxytocin in female social behavior. Biol. Psychol. 2008, 77:1-10.
17. Campbell A. Oxytocin and human social behavior. Pers. Soc. Psychol. Rev. 2010, 14:281-295.
18. Cardoso C., Ellenbogen M.A., Linnen A.M. Acute intranasal oxytocin improves positive self-perceptions of personality. Psychopharmacology (Berlin) 2012, 220:741-749.
19. Cardoso C., Linnen A.M., Joober R., Ellenbogen M.A. Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. Exp. Clin. Psychopharm. 2012, 20:84-91.
20. Carter C.S., Pournajafi-Nazarloo H., Kramer K.M., Ziegler T.E., White-Traut R., Bello D., Schwertz D. Oxytocin: behavioral associations and potential as a salivary biomarker. Ann. N.Y. Acad. Sci. 2007, 1098:312-322.
21. Chao H.-F. Dissociations between identity and location negative priming. Acta Psychol. (Amst.) 2011, 136:81-89.
22. Costa P.T.Jr., McCrae R.R. Revised NEO Personality Inventory (NEO PI-R): Professional Manual 1992, NIH National Institute on Aging Gerontology Research Center: Laboratory of Personality and Cognition, Baltimore, MD, USA.
23. De Dreu C.K.W., Greer L.L., Handgra M.J.J., Shalvi S., Van Kleef G.A., Baas M., Ten Velden F.S., Van Dijk E., Feith S.W.W. The neuropeptide oxytocin regulates parochial altruism intergroup conflict among humans. Science 2010, 328:1408-1411.
24. Declerck C.H., Boone C., Kiyonari T. Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Horm. Behav. 2010, 57:368-374.
25. Di Simplicio M., Massey-Chase R., Cowen P.J., Harmer C.J. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J. Psychopharm. 2009, 23:241-248.
26. Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol. Psychiatry 2009, 65:728-731.
27. Domes G., Heinrichs M., Gläscher J., Büchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
28. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S.C. Oxytocin improves 'mind-reading' in humans. Biol. Psychiatry 2007, 61:731-733.
29. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
30. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
31. Egner T., Hirsch J. Where memory meets attention: neural substrates of negative priming. J. Cogn. Neurosci. 2005, 17:1774-1784.
32. Ellenbogen M.A., Schwartzman A.E. Selective attention and avoidance on a pictorial cueing task during stress in clinically anxious and depressed participants. Behav. Res. Ther. 2009, 47:128-138.
33. Ellenbogen M.A., Linnen A.M., Grumet R., Cardoso C., Joober R. The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology 2012, 49:128-137.
34. Eugène F., Joormann J., Cooney R.E., Atlas L.Y., Gotlib I.H. Neural correlates of inhibitory deficits in depression. Psychiatry Res. 2010, 181:30-35.
35. Fergusson D.M., Horwood L.J., Ridder E.M., Beautrais A.L. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch. Gen. Psychiatry 2005, 62:66-72.
36. Friedman N.P., Miyake A. The relations among inhibition and interference control functions: a latent-variable analysis. J. Exp. Psychol. Gen. 2004, 133:101-135.
37. Frings C., Wentura D., Holtz M. Dysphorics cannot ignore unpleasant information. Cogn. Emot. 2007, 21:1525-1534.
38. Gamer M., Zurowski B., Büchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9400-9405.
39. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
40. Goeleven E., De Raedt R., Baert S., Koster E.H.W. Deficient inhibition of emotional information in depression. J. Affect. Disord. 2006, 93:149-157.
41. Gotlib I.H., Krasnoperova E., Yue D.N., Joormann J. Attentional biases for negative interpersonal stimuli in clinical depression. J. Abnorm. Psychol. 2004, 113:127-135.
42. Guastella A.J., Mitchell P.B., Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biol. Psychiatry 2008, 63:3-5.
43. Guastella A.J., Mitchell P.B., Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol. Psychiatry 2008, 64:256-258.
44. Guastella A.J., Carson D.S., Dadds M.R., Mitchell P.B., Cox R.E. Does oxytocin influence the early detection of angry and happy faces?. Psychoneuroendocrinology 2009, 34:220-225.
45. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009, 34:917-923.
46. Gunthert K.C., Cohen L.H., Armeli S. The role of neuroticism in daily stress and coping. J. Pers. Soc. Psychol. 1999, 77:1087-1100.
47. Harony H., Wagner S. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neurosignals 2010, 18:82-97.
48. Harrison N.A., Wilson C.E., Critchley H.D. Processing of observed pupil size modulates perception of sadness and predicts empathy. Emotion 2007, 7:724-729.
49. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol. Psychiatry 2009, 14:954-958.
50. Higashida H., Lopatina O., Yoshihara T., Pichugina Y.A., Soumarokov A.A., Munesue T., Minabe Y., Kikuchi M., Ono Y., Korshunova N., Salmina A.B. Oxytocin signal and social behaviour: comparison among adult and infant oxytocin, oxytocin receptor and CD38 gene knockout mice. J. Neuroendocrinol. 2010, 22:373-379.
51. Ignashchenkova A., Dicke P.W., Haarmeier T., Thier P. Neuron-specific contribution of the superior colliculus to overt and covert shifts of attention. Nat. Neurosci. 2004, 7:56-64.
52. Insel T.R. A neurobiological basis of social attachment. Am. J. Psychiatry 1997, 154:726-735.
53. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010, 65:768-779.
54. Joiner T.E., Timmons K.A. Depression in its interpersonal context. Handbook of Depression 2009, 322-339. Guilford Press, New York. 2nd ed. I.H. Gotlib, C.L. Hammen (Eds.).
55. Joormann J. Attentional bias in dysphoria: the role of inhibitory processes. Cogn. Emot. 2004, 18:125-147.
56. Joormann J. Differential effects of rumination and dysphoria on the inhibition of irrelevant emotional material: Evidence from a negative priming task. Cogn. Ther. Res. 2006, 30:149-160.
57. Joormann J., Gotlib I.H. Emotion regulation in depression: relation to cognitive inhibition. Cogn. Emot. 2010, 24:281-298.
58. Kendrick K.M. Oxytocin, motherhood and bonding. Exp. Physiol. 2000, 85:111S-124S.
59. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
60. Krueger F., Fischer R., Heinecke A., Hagendorf H. An fMRI investigation into the neural mechanisms of spatial attentional selection in a location-based negative priming task. Brain Res. 2007, 1174:110-119.
61. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
62. Leung K.K., Lee T.M.C., Won M.M.C., Li L.S.W., Yip P.S.F., Khong P.L. Neural correlates of attention biases of people with major depressive disorder: a voxel-based morphometric study. Psychol. Med. 2009, 39:1097-1106.
63. Loup F., Tribollet E., Dubois-Dauphin M., Dreifuss J.J. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res. 1991, 555:220-232.
64. Lukas M., Toth I., Reber S.O., Slattery D.A., Veenema A.H., Neumann I.D. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 2011, 36:2159-2168.
65. Lundqvist D., Flykt A., öhman A. The Karolinska Directed Emotional Faces-KDEF, CD ROM 1998, Department of Clinical Neuroscience, Psychology Section, Karolinska Institute, Stockholm.
66. MacLeod C.M., Chiappe D.L., Fox E.F. The crucial roles of stimulus matching and stimulus identity in negative priming. Psychon. Bull. Rev. 2002, 9:521-528.
67. MacLeod C.M., Dodd M.D., Sheard E.D., Wilson D.E., Bibi U. In opposition of inhibition. The Psychology of Learning and Motivation 2003, vol. 43:163-214. Academic Press, San Diego, CA.
68. MacQueen G.M., Galway T., Goldberg J.O., Tipper S.P. Impaired distractor inhibition in patients with schizophrenia on a negative priming task. Psychol. Med. 2003, 33:121-129.
69. Marsh A.A., Yu H.H., Pine D.S., Blair R.J.R. Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berlin) 2010, 209:225-232.
70. Matthews S., Simmons A., Strigo I., Gianaros P., Yang T., Paulus M. Inhibition-related activity in subgenual cingulate is associated with symptom severity in major depression. Psychiatry Res. Neuroimmunol. 2009, 172:1-6.
71. Matthews S.C., Strigo I.A., Simmons A.N., Yang T.T., Paulus M.P. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J. Affect. Disord. 2008, 111:13-20.
72. Meynen G., Unmehopa U.A., Hofman M.A., Swaab D.F., Hoogendijk W.J. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol. Psychiatry 2007, 12:118-119.
73. Mikolajczak M., Pinon N., Lane A., de Timary P., Luminet O. Oxytocin not only increases trust when money is at stake, but also when confidential information is in the balance. Biol. Psychol. 2010, 85:182-184.
74. Naber F., van Ijzendoorn M.H., Deschamps P., van Engeland H., Bakermans-Kranenburg M.J. Intranasal oxytocin increases fathers' observed responsiveness during play with their children: a double-blind within-subject experiment. Psychoneuroendocrinology 2010, 35:1583-1586.
75. Neumann I.D. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol. Bull. 2008, 20:858-865.
76. Nigg J.T. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol. Bull. 2000, 126:220-246.
77. Norman G.J., Cacioppo J.T., Morris J.S., Malarkey W.B., Berntson G.G., DeVries A.C. Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol. Psychol. 2011, 86:174-180.
78. O'Connor L.E., Berry J.W., Weiss J., Gilbert P. Guilt, fear, submission, and empathy in depression. J. Affect. Disord. 2002, 71:19-27.
79. Ochsner K.N., Gross J.J. The cognitive control of emotion. Trends Cogn. Sci. 2005, 9:242-249.
80. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res. 2009, 169:249-252.
81. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., Schatzberg A.F. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res. 2010, 178:359-362.
82. Pedersen C.A. Oxytocin control of maternal behavior: regulation by sex steroids and offspring stimuli. Ann. N.Y. Acad. Sci. 1997, 807:126-145.
83. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
84. Pitts A.F., Samuelson S.D., Meller W.H., Bissette G. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biol. Psychiatry 1995, 38:330-335.
85. Posner M.I., Nissen M.J., Ogden W.C. Attended and unattended processing modes: the role of set for spatial location. Modes of Perceiving and Processing Information 1978, 137-157. Erlbaum, Hillsdale, NJ. H.L.,.J. Pick, E. Saltzman (Eds.).
86. Posner M.I., Petersen S.E. The attention system of the human brain. Annu. Rev. Neurosci. 1990, 13:25-42.
87. Quirin M., Kuhl J., Dusing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology 2011, 36:898-904.
88. Rimmele U., Hediger K., Heinrichs M., Klaver P. Oxytocin makes a face in memory familiar. J. Neurosci. 2009, 29:38-42.
89. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
90. Savaskan E., Ehrhardt R., Schulz A., Walter M., Schachinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 2008, 33:368-374.
91. Schulze L., Lischke A., Greif J., Herpertz S.C., Heinrichs M., Domes G. Oxytocin increases recognition of masked emotional faces. Psychoneuroendocrinology 2011, 36:1378-1382.
92. Shamay-Tsoory S.G., Fischer M., Dvash J., Harari H., Perach-Bloom N., Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol. Psychiatry 2009, 66:864-870.
93. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
94. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
95. Taylor V.A., Ellenbogen M.A., Washburn D., Joober R. The effects of glucocorticoids on the inhibition of emotional information: a dose-response study. Biol. Psychol. 2011, 86:17-25.
96. Theodoridou A., Rowe A.C., Penton-Voak I.S., Rogers P.J. Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness. Horm. Behav. 2009, 56:128-132.
97. Tipper S.P. The negative priming effect: inhibitory priming by ignored objects. Q. J. Exp. Psychol. 1985, 37:571-590.
98. Tipper S.P., Cranston M. Selective attention and priming: inhibitory and facilitatory effects of ignored primes. Q. J. Exp. Psychol. 1985, 37:591-611.
99. Tipper S.P. Does negative priming reflect inhibitory mechanisms? A review and integration of conflicting views. Q. J. Exp. Psychol. A 2001, 54A:321-343.
100. Ungar L., Nestor P.G., Niznikiewicz M.A., Wible C.G., Kubicki M. Color stroop and negative priming in schizophrenia: an fMRI study. Psychiatry Res. Neuroimmunol. 2010, 181:24-29.
101. Unkelbach C., Guastella A.J., Forgas J.P. Oxytocin selectively facilitates recognition of positive sex and relationship words. Psychol. Sci. 2008, 19:1092-1094.
102. van Londen L., Goekoop J.G., van Kempen G.M.J., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997, 17:284-292.
103. Young L.J., Lim M.M., Gingrich B., Insel T.R. Cellular mechanisms of social attachment. Horm. Behav. 2001, 40:133-138.
104. Zetsche U., Joormann J. Components of interference control predict depressive symptoms and rumination cross-sectionally and at six months follow-up. J. Behav. Ther. Exp. Psychiatry 2011, 42:65-73.